Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Bertrand, Pourroy"'
Autor:
Ming Kei Lee, Sama Seyedmousavi, Sylvain Auvity, Bertrand Pourroy, Vincent Elleboode, Isabelle Kachaner, Christel Jansen, Herve Lilliu
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
ObjectiveTo evaluate the potential impact of cell and gene therapies (CGTs) in France by forecasting the number of patients that will be treated with CGTs over the period 2023–2030 by therapeutic area and region.MethodsA review of CGTs in clinical
Externí odkaz:
https://doaj.org/article/bb8bd8683d894df29fa28cd445fdebd0
Autor:
François Becher, Joseph Ciccolini, Diane-Charlotte Imbs, Clémence Marin, Claire Fournel, Charlotte Dupuis, Nicolas Fakhry, Bertrand Pourroy, Aurélie Ghettas, Alain Pruvost, Christophe Junot, Florence Duffaud, Bruno Lacarelle, Sebastien Salas
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-11 (2017)
Abstract Administration of first-in-class anti-EGFR monoclonal antibody cetuximab is contingent upon extensive pharmacogenomic testing. However in addition to tumor genomics, drug exposure levels could play a critical, yet largely underestimated role
Externí odkaz:
https://doaj.org/article/59b1810b3de1458f856d8917cd3a443c
Autor:
Nadine Houédé, Cécile Flahault, Marine Gross-Goupil, Solenn Le Clanche, Yann Le Goff, Frédérick Merlier, Géraldine Pignot, Bertrand Pourroy, Constance Thibault, Evanguelos Xylinas, Marie-Noelle Solbes, Gwenael Dénéchère, Morgan Roupret
Publikováno v:
Bulletin du Cancer. 109:925-937
Publikováno v:
Annales Pharmaceutiques Françaises.
Autor:
Diane Braguer, Claudette Briand, Anna Kruczynski, Véronique Bourgarel-Rey, Eddy Pasquier, Stéphane Honoré, Bertrand Pourroy
Angiogenesis is a key event in tumor progression and metastasis. This complex process, which constitutes a potent target for cancer therapy, is inhibited by very low concentrations of microtubule-targeting drugs (MTD). However, the intimate mechanism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::280baf1da778a50d3971ec5ba4722b53
https://doi.org/10.1158/0008-5472.c.6494802.v1
https://doi.org/10.1158/0008-5472.c.6494802.v1
Autor:
Diane Braguer, Claudette Briand, Anna Kruczynski, Véronique Bourgarel-Rey, Eddy Pasquier, Stéphane Honoré, Bertrand Pourroy
Supplementary Figure 1 from Antiangiogenic Concentrations of Vinflunine Increase the Interphase Microtubule Dynamics and Decrease the Motility of Endothelial Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d925f720054ba147caccaaf0dc5236b
https://doi.org/10.1158/0008-5472.22365651.v1
https://doi.org/10.1158/0008-5472.22365651.v1
Autor:
Christophe Bardin, Bertrand Pourroy, Catherine Rioufol, Jean Francois Tournamille, Isabelle Madelaine, Régine Chevrier, Florian Slimano
Publikováno v:
JCO Oncology Practice. 16:e1282-e1290
PURPOSE: Patients with cancer are at higher risk for contracting the COVID-19 infection and are more likely to have higher morbidity and mortality. This is a big challenge for oncology teams that have to treat patients to avoid contamination by SARS-
Publikováno v:
American Journal of Clinical Oncology. 45:403-404
Autor:
Innocent Krasse, Christophe Curti, Jauhel N'Gbesso, Bertrand Pourroy, Edouard Lamy, Patrice Vanelle
Publikováno v:
Journal of Pain and Symptom Management
Journal of Pain and Symptom Management, Elsevier, 2020, 59 (1), pp.e10-e13. ⟨10.1016/j.jpainsymman.2019.10.005⟩
Journal of Pain and Symptom Management, 2020, 59 (1), pp.e10-e13. ⟨10.1016/j.jpainsymman.2019.10.005⟩
Journal of Pain and Symptom Management, Elsevier, 2020, 59 (1), pp.e10-e13. ⟨10.1016/j.jpainsymman.2019.10.005⟩
Journal of Pain and Symptom Management, 2020, 59 (1), pp.e10-e13. ⟨10.1016/j.jpainsymman.2019.10.005⟩
International audience; The purpose of our study was to develop an affordable and easily available oral morphine formulation for pediatric patients with cancer pain.We devised an easy-to-make and low-cost morphine syrup formulation using local Africa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d658e51421ebf029781f77880ecf952a
https://hal.archives-ouvertes.fr/hal-03189262/document
https://hal.archives-ouvertes.fr/hal-03189262/document
Autor:
Sarah Giacometti, Bruno Lacarelle, Ariel Savina, Manon Carré, Bertrand Pourroy, Fanny Bouquet, Anne Rodallec, Guillaume Sicard, Raphaelle Fanciullino, Joseph Ciccolini
Publikováno v:
International Journal of Nanomedicine
International Journal of Nanomedicine, Dove Medical Press, 2018, 13, pp.6677-6688. ⟨10.2147/IJN.S179290⟩
International Journal of Nanomedicine, 2018, 13, pp.6677-6688. ⟨10.2147/IJN.S179290⟩
International Journal of Nanomedicine, Dove Medical Press, 2018, 13, pp.6677-6688. ⟨10.2147/IJN.S179290⟩
International Journal of Nanomedicine, 2018, 13, pp.6677-6688. ⟨10.2147/IJN.S179290⟩
Anne Rodallec,1 Guillaume Sicard,1 Sarah Giacometti,1 Manon Carré,1 Bertrand Pourroy,2 Fanny Bouquet,3 Ariel Savina,3 Bruno Lacarelle,1 Joseph Ciccolini,1 Raphaelle Fanciullino1 1SMARTc Unit, Laboratory of Pharmacokinetics and Toxicology UFR Pharmac